Discover and read the best of Twitter Threads about #GBM

Most recents (14)

@annenbcnews
Hi Anne, my husband was dx w/ a #GBM in May 2022. I'm confused by how you did a GBM story w/o discussing the most significant development ever for brain tumors.

Please follow up with #UCLA & #NWBO #DCVAX. Completed P3 last May, approved for UK Specials already &
1/
is a personalized, nontoxic vaccine. It has given patients w/ a 10-18 month prognosis 9, 12, 16, 20+ years & counting with no addtl treatment.

My husband is a 52 yo firefighter and we are counting on #DCVAX to save his life. He doesn't have time for the treatment you covered
2/
This vaccine was created in the US and UK will have full approval before the US, forcing US patients like @Clairotonin, a 36 yo ICU nurse who desperately needs it, to try to get to the UK at a cost of $300k

We need #DCVAX approved by @US_FDA for compassionate use ASAP and
3/
Read 5 tweets
@BerkeleyJr
While I'm glad you covered #GBM tumors, you missed the headline. Instead of sharing the incredible successes of #NWBO #DCVAX and how many patients have gone 9, 12, 16, 21 years and counting w/ no addtl treatment, you focused on a Phase 2.

1/
Phase 3 was presented last May. JAMA included in their journal and 60 top docs signed on. Plus the combo trial with Keytruda and Poly-ICLC is incredible.

#DCVAX is helping people NOW. It was created at UCLA and trials were conducted in the UK, CANADA, and GERMANY too.

2/
The UK has already approved for Private Pay/ Compassionate Use and full approval should be soon.

As the wife of a #GBM patient who lost her father-in-law to this horrid disease 22 years ago, I wish you would've included the most hopeful and current option, #DCVAX.

3/
Read 5 tweets
Patients with #glioma often experience altered cognition but it was unknown whether tumors remodel or destroy neuronal circuits in the human brain. New, open access #CancerNeuroscience paper: nature.com/articles/s4158….
In our study led by talented @NeurosurgUCSF post doc @SarithaKrishnaa and collaborators @michelle_monje, @DavidJBrang @LabRaleigh @AnnetteMolinar2, we found that glioblastomas remodel circuits.
Intraoperative recordings in awake people with left hemisphere #GBM show us that speech production activates glioma-infiltrated cortex, and GBM remodels speech circuitry so that producing speech activates all of the glioma-infiltrated cortex.
Read 8 tweets
🚀 #DeTasker's IDO is on it's way! We're committed to a fair launch, with no presale or VC backing. Don't miss out on this opportunity to be part of the future of decentralized freelancing! Learn why we chose #WigoSwap and how we're utilizing their #WigoRun and #GBM features. Image
🎯 Fair Launch: #DeTasker believes in equal opportunities for all. Our decision to avoid presales and VC backing ensures a level playing field for our community members. Participate in our IDO for a truly fair and transparent token distribution.
💡 Partnering with #WigoSwap for our IDO allows #DeTasker to leverage their innovative #WigoRun feature, ensuring a seamless and secure token sale. WigoSwap's robust platform aligns perfectly with our vision for the future of decentralized freelancing.
Read 5 tweets
Granted: Commercial manufacturing license (MIA) at Sawston, for CDMO Advent at the $NWBO owned factory for manufacturing #DCVaxL, it’s successful #cancervaccine for #GBM & any solid tumor ultimately.

Next step, Marketing Approval, BLA.

cms.mhra.gov.uk/mhra/mia/uk-mi…
Background:

Northwest Biotherapeutics Announces Filing of Application for License for Commercial Manufacturing at Sawston, UK Facility

From July 6, 2022

nwbio.com/northwest-biot…
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients w/Newly Diagnosed & Recurrent Glioblastoma: Phase 3 Prospective Externally Controlled Cohort Trial | JAMA Oncology $NWBO #DCVaxL #Phase3

jamanetwork.com/journals/jamao…
Read 7 tweets
Commercial manufacturing license for designated contract manufacturing manager for Sawston, the $NWBO factory for manufacturing #DCVaxL, it’s successful #cancervaccine for solid tumors, first for #GBM

Next step, commercial marketing approval, BLA, etc.

cms.mhra.gov.uk/mhra/mia/uk-mi
Background:

Northwest Biotherapeutics Announces Filing of Application for License for Commercial Manufacturing at Sawston, UK Facility

From July 6, 2022

nwbio.com/northwest-biot…
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients w/Newly Diagnosed & Recurrent Glioblastoma: Phase 3 Prospective Externally Controlled Cohort Trial | JAMA Oncology $NWBO #DCVaxL #Phase3

jamanetwork.com/journals/jamao…
Read 6 tweets
Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy from 2011, #DCVaxL with #PolyICLC #Glioblastoma #GBM

aacrjournals.org/clincancerres/…
#DCVaxL & #PolyICLC #TLR3Inhibitor as adjuvant, have been an impressive combination since 2011:

Results: DC vaccinations are safe and not associated with any dose-limiting toxicity.
The median overall survival from the time of initial surgical diagnosis of glioblastoma was 31.4 months, with a 1-, 2-, and 3-year survival rate of 91%, 55%, and 47%, respectively.
Read 7 tweets
Relatively New Program at FDA:

CDER’s Accelerating Rare disease Cures (ARC) Program via @YouTube

$NWBO #DCVaxL #GBM #orphandesignation
Accelerating Rare disease Cures (ARC) Program

CDER's ARC Program | Center for Drug Evaluation and Research (CDER)

fda.gov/about-fda/cent…
Skip down to the substantive parts …

fda.gov/media/160996/d…
Read 3 tweets
‘I’m just carrying on’: vaccine gives brain cancer patient years of extra life

The revolutionary DCVax-L vaccine has allowed Nigel French to live a normal life seven years after a brain cancer diagnosis #DCVaxL $NWBO #CancerVaccine #Glioblastoma #Phase3

theguardian.com/science/2022/n…
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma $NWBO #DCVaxL #CancerVaccine #GBM

A Phase 3 Prospective Externally Controlled Cohort Trial

jamanetwork.com/journals/jamao…
More long-term Survivors, $NWBO #DCVaxL a personalized general therapeutic #CancerVaccine to treat any kind of solid tumor cancer anywhere in the body.

Read 4 tweets
Exploring Adjuvants with #DCVaxL: POLY ICLC TLR 3 Agonist adjuvant discussion, #DrLindaLiau, early trial P 1. Using adjuvants w/ #DCVaxL $NWBO #Murcidencel #DCVax

Survival Data w/Adjuvants, small early trial:
Fuller Discussion re early trial with #DCVaxL + adjuvants, including Poly ICLC:
Re single agent checkpoint inhibitors, without DCVaxL, in Glioblastoma:
Read 13 tweets
And the road to ⁦@MICCAI_Society⁩ ⁦@MiccaiS#Singapore has started! Cannot wait to present #ImagineQuant@YaleRadiology#BrainLesWorkshop 20 hrs travel totally worth it 😅😎❤️ to learn from the best #MICCAI22. ⁦@ujjwalbaid0408⁩ ⁦@SpyridonBakasImageImage
Goodbye #Newark #NYC, looking forward to #Tokyo in 12 hrs! Dreams do come true!!! #academiclife #neurorad Thinking of @hsairmd @sairaallapeikko @theASFNR #Maui just about now! Will have to finish that episode 13 soon! @MICCAI_Society @MiccaiStudents @WomenInMICCAI #ImagineQuant Image
Read 5 tweets
1/ Re $NWBO and #DCVaxL aka "ATL-DC" in brief:

#DrLindaLiau, principal investigator for a Phase 3 #DCVaxL trial recently gave a lecture covering the #DCVaxLComboTrial with #Keytruda.
2/ $NWBO and UCLA have a patent application pending approval for immunotherapy combinations with #DCVaxL.
3/ The #DCVaxLComboTrial appears to be intended to further the patent process and also to likely advance new commercial opportunities, including potential partnerships, for $NWBO. Many commentators have suggested some obvious potential partners.
Read 33 tweets
1) Welcome to a new #accredited #tweetorial on the #goKDIGO guidance regarding evaluation and management of focal segmental glomerulosclerosis (#FSGS)--one of the most common causes of primary glomerular disease in adults. Leading us through this material is @edgarvlermamd.
2) Dr. Lerma is core faculty at both @ckd_ce & @cardiomet_CE and is an expert #nephrologist and #educator. This tweetorial is accredited for 0.5h CE/#CME for #physicians #nurses #NPs #PAs #pharmacists. Please follow along!
3) This educational program is supported by grants from Travere, Bayer, & Otsuka, and is intended for healthcare providers. Faculty disclosures can be found at ckd-ce.com/disclosures/. Past programs, still available for CE/#CME credit, are at ckd-ce.com.
Read 34 tweets
Proud of this @NatureMedicine collaboration with #FeedmanLab on a novel method detecting early stage RCC in plasma&urine w/cell-free DNA methylomes. Work led by super stars @PierVitaleNuzzo @Jberchuck @keegankorthauer #SandorSpisak
1/ RCC kills 175,000 patients worldwide with no screening test available acsjournals.onlinelibrary.wiley.com/doi/full/10.33….
A screening test that detects RCC while still localized (2/3 RCCs) will possibly reduce mortality. RCC and CNS tumors do not shed much cfDNA in the blood!
2/ Developed initially by @decarvalho_lab (co-senior author), we validated this ultra-sensitive cfMeDIP-seq using plasma cfDNA and, for the 1st time, cfDNA from urine samples collected in our #GelbCenter (Chair M. Pomerantz)
Read 13 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!